The value in the PRV is actually NOT selling it. The faster paxalisib is brought to market then the faster it can be used in multiple indications. Unless, the whole drug and PRV is on sold.
Week 44 Wrap: Relatively boring week ahead of US election; HotCopper's most watched; Oz inflation at 3.5%
MKT The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint
